Table of Content

Open Access iconOpen Access

ARTICLE

Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma

Ewa Lech-Maranda1,2, Jacques Bienvenu1,4, Anne-Sophie Michallet3, Roch Houot3, Tadeusz Robak2, Bertrand Coiffier1,3, Gilles Salles1,3

1 Equipe d’Accueil «Pathologie des Cellules Lymphoïdes », Université Claude Bernard, Lyon, France
2 Department of Hematology, Medical University of Lodz, Poland
3 Service d’Hématologie, Centre-Hospitalier Lyon-Sud, 69495 Pierre-Bénite, France
4 Laboratoire d’Immunologie, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France

* Corresponding Author: G. Salles, email

European Cytokine Network 2006, 17(1), 60-66.

Abstract

The aim of the study was to confirm whether plasma levels of interleukin-10 (IL-10) correlate with the prognosis in diffuse, large B-cell lymphoma (DLBCL) patients. Plasma IL-10 levels were determined at the time of diagnosis in a group of 157 consecutively treated, DLBCL patients. Of those, 122 patients (78%) had IL-10 plasma levels below the detection limit (< 5 pg/mL) and 35 (22%) above this value. The median value for patients with detectable IL-10 levels was 35 pg/mL (range, 5 to 2480 pg/mL). Detectable plasma IL-10 levels were significantly associated with age > 60 years, ECOG performance status ≥ 2, Ann Arbor advanced disease stage, bulky tumor mass, elevated serum levels of LDH and b2-microglobulin, presence of anemia and low serum albumin levels as well as the presence of B symptoms. The patients with detectable IL-10 levels had lower probability of CR achievement (OR = 0.23, 95% CI 0.1-0.5, p = 0.0003). In addition, detectable IL-10 levels were significantly associated with shorter PFS (OR = 2.5, 95% CI 1.5-4.4, p = 0.001) and OS (OR = 3.0, 95% CI 1.7-5.2, p = 0.0001). In conclusion, we confirmed in this large group of DLBCL patients that elevated plasma IL-10 levels correlated with adverse disease features and poor prognosis. The plasma concentration of IL-10 may be a useful marker for evaluation of disease activity.

Keywords

interleukin-10, lymphoma, International Prognostic Index

Cite This Article

APA Style
Lech-Maranda, E., Bienvenu, J., Michallet, A., Houot, R., Robak, T. et al. (2006). Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma. European Cytokine Network, 17(1), 60–66.
Vancouver Style
Lech-Maranda E, Bienvenu J, Michallet A, Houot R, Robak T, Coiffier B, et al. Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma. Eur Cytokine Network. 2006;17(1):60–66.
IEEE Style
E. Lech-Maranda et al., “Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma,” Eur. Cytokine Network, vol. 17, no. 1, pp. 60–66, 2006.



cc Copyright © 2006 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 51

    View

  • 22

    Download

  • 0

    Like

Share Link